Linda Cashin-Hemphill

Statistics

Publications

Citations

1.7K

H-Index

Active since

1987

Affiliations

University of Southern California(Current)

Heart Foundation

University of Michigan

Harvard–MIT Division of Health Sciences and Technology

Institute for Atherosclerosis Research

Linda Cashin-Hemphill is an author at University of Southern California specializing in medicine, cardiovascular pharmacotherapy, and coronary artery disease.

Publications per year

1987–2003

Publications

Beneficial Effects of Colestipol-Niacin on Coronary Atherosclerosis

Linda Cashin-Hemphill · JAMA · 1990 · 489 citations

Medicine, Cardiology, Pharmacology +16

Hormone Therapy and the Progression of Coronary-Artery Atherosclerosis in Postmenopausal Women

Howard N. Hodis, Wendy J. Mack, Stanley P. Azen et al. · New England Journal of Medicine · 2003 · 383 citations · Full text

Medicine, Cardiology, Endocrinology +17

The Quinapril Ischemic Event Trial (QUIET): evaluation of chronic ace inhibitor therapy in patients with ischemic heart disease and preserved left ventricular function

Bertram Pitt, Blair J. O’Neill, Robert Feldman et al. · The American Journal of Cardiology · 2001 · 230 citations

Medicine, Cardiology, Pharmacology +13

Progression of Coronary Artery Disease Predicts Clinical Coronary Events

Stanley P. Azen, Wendy J. Mack, Linda Cashin-Hemphill et al. · Circulation · 1996 · 215 citations

Medicine, Cardiology, Surgery +17

Beneficial effects of colestipol-niacin on coronary atherosclerosis. A 4-year follow-up

Linda Cashin-Hemphill · JAMA · 1990 · 118 citations

Medicine, Cardiology, Pharmacology +17

1–5 of 12